Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

被引：6
|
作者：
Mambet, Cristina [1 ,2 ,3 ]
Babosova, Olga [4 ]
Defour, Jean-Philippe [2 ,5 ]
Leroy, Emilie [1 ,2 ]
Necula, Laura [3 ]
Stanca, Oana [6 ,7 ]
Tatic, Aurelia [7 ,8 ]
Berbec, Nicoleta [6 ,7 ]
Coriu, Daniel [7 ,8 ]
Belickova, Monika [9 ]
Kralova, Barbora [10 ]
Lanikova, Lucie [4 ]
Vesela, Jitka [9 ]
Pecquet, Christian [1 ,2 ]
Saussoy, Pascale [5 ]
Havelange, Violaine [11 ]
Diaconu, Carmen C. [3 ]
Divoky, Vladimir [10 ]
Constantinescu, Stefan N. [1 ,2 ,3 ]
机构：
[1] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium
[2] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium
[3] Stefan S Nicolau Inst Virol, Mol Profiling Myeloproliferat Neoplasms & Acute L, Bucharest, Romania
[4] Acad Sci Czech Republ, Inst Mol Genet, Dept Cell & Dev Biol, Prague, Czech Republic
[5] Catholic Univ Louvain, Clin Univ St Luc, Dept Biol Clin, Brussels, Belgium
[6] Coltea Clin Hosp, Dept Hematol, Bucharest, Romania
[7] Carol Davila Univ Med & Pharm, Dept Radiol Oncol & Hematol, Bucharest, Romania
[8] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania
[9] Inst Hematol & Blood Transfus, Prague, Czech Republic
[10] Palacky Univ, Fac Med & Dent, Dept Biol, Hnevotinska 3, CZ-77515 Olomouc, Czech Republic
[11] Clin Univ St Luc, Serv Hematol, Brussels, Belgium
来源：
BLOOD | 2018年 / 132卷 / 25期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA;
D O I：
10.1182/blood-2018-04-843060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2695 / 2699
页数：7
相关论文
共 50 条
  • [31] A molecular diagnostic algorithm for JAK2 V617F investigations in suspected myeloproliferative neoplasms
    Catherwood, Mark Alexander
    McAllister, Roisin
    McCallion, Patrick
    McGimpsey, Julie Elizabeth
    Hindley, Andrew
    Feerick, John
    Greenfield, Greame
    Kennedy, Paul
    Benson, Gary
    Arnold, Claire
    Merron, Bridgin
    McMullin, Mary Frances
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (02) : 621 - 626
  • [32] AT9283, a potent inhibitor of JAK2, is active in JAK2 V617F myeloproliferative disease models
    Squires, Matthew S.
    Cuny, Jayne E.
    Dawson, Mark A.
    Scott, Mike A.
    Barber, Kelly
    Reule, Matthias
    Smyth, Tomoko
    Wallis, Nicola
    Yule, Murray
    Thompson, Neil T.
    Lyons, John F.
    Green, Anthony K.
    BLOOD, 2007, 110 (11) : 1035A - 1035A
  • [33] Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype
    Cross, Nicholas C. P.
    Jones, Amy V.
    Silver, Richard T.
    Oscier, David
    Metzgeroth, Georgia
    Wang, Y. Lynn
    Collins, Andrew
    Reiter, Andreas
    Grand, Francis
    Chase, Andrew
    BLOOD, 2008, 112 (11) : 71 - 71
  • [34] JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms
    Siemiatkowska, Anna
    Bieniaszewska, Maria
    Hellmann, Andrzej
    Limon, Janusz
    LEUKEMIA RESEARCH, 2010, 34 (03) : 387 - 389
  • [35] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [36] Comparison of JAK2 V617F positive and negative myeloproliferative diseases
    Szilvasi, A.
    Andrikovics, H.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 379
  • [37] A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F)
    Zhao, Lequn
    Ma, Yue
    Seemann, Joachim
    Huang, Lily Jun-Shen
    BIOCHEMICAL JOURNAL, 2010, 426 : 91 - 98
  • [38] Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
    Andrikovics, H.
    Szilvasi, A.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S124 - S124
  • [39] REAL TIME DETECTION OF JAK2 V617F IN THE MYELOPROLIFERATIVE DISORDERS
    Goday-Fernandez, A.
    Boyd, E. M.
    Bench, A. J.
    Erber, W. N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 302 - 302
  • [40] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
12345